Overview
GPT-Rosalind-5.5 is an OpenAI reasoning model specialized for enterprise-scale life sciences research. Incrementally trained from GPT-5.5, it combines agentic coding and tool use with capabilities for biology, drug discovery and translational medicine. Outside biology, OpenAI describes its capabilities as comparable to GPT-5.5. (openai.com)
Capabilities and uses
- Analyze and reconcile scientific evidence across literature, genomics, transcriptomics, sequences, structures and experimental results.
- Support medicinal chemistry tasks, including structure–activity relationships, potency and toxicity prediction, lead optimization and retrosynthesis.
- Assist with quantitative biology, genomics analysis and wet-lab troubleshooting.
- Work with OpenAI’s Life Sciences Research and Life Sciences NGS Analysis plugins to retrieve evidence, perform bioinformatics workflows and preserve artifacts for review. (openai.com)
In OpenAI’s evaluations, GPT-Rosalind scored 27.5% versus GPT-5.5’s 25.1% on MedChemBench, 21.6% versus 20.4% on GeneBench, and 63.2% versus 55.8% on LabWorkBench. These are benchmark results, not guarantees of performance in a particular workflow. (openai.com)
Access and limitations
Access is restricted to eligible organizations through OpenAI’s trusted-access program, with governance, safety and security requirements. The announcement was updated on September 11, 2026 to say that GPT-Rosalind was leaving research preview and becoming available globally to eligible organizations. Research outputs should be reviewed by qualified experts. OpenAI assessed the model’s biological and chemical capabilities as meeting its High capability threshold, while remaining below its Critical threshold, and applied additional safeguards. (openai.com)
Pricing
As checked on November 16, 2026, OpenAI’s ChatGPT Enterprise token-based rate card lists both GPT-5.5 Rosalind Research and GPT-5.5 Rosalind Discovery at USD $5.00 per million input tokens, $0.50 per million cached input tokens, and $25.00 per million output tokens. These rates apply to supported ChatGPT Work and Codex activity under applicable Enterprise agreements; access approval requirements apply. (help.openai.com)
OpenAI’s API pricing also lists gpt-rosalind-research at USD $5.00 per million input tokens, $0.50 per million cached input tokens and $25.00 per million output tokens, with billing beginning October 5, 2026. This is a separately listed API offering; the input did not provide a model ID, and the rate should not be treated as proof of a fixed GPT-Rosalind-5.5 API snapshot. Cache-write pricing does not apply to that API offering. (developers.openai.com)
Release and official sources
- Publication date: June 3, 2026.
- Official announcement
- GPT-Rosalind-5.5 system card
- ChatGPT Enterprise token-based rate card
- OpenAI API pricing